Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses

por Nguyen, Jack T., Smee, Donald F., Barnard, Dale L., Julander, Justin G., Gross, Matthew, de Jong, Menno D., Went, Gregory T.
Publicado 2012

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

por Hoopes, Justin D., Driebe, Elizabeth M., Kelley, Erin, Engelthaler, David M., Keim, Paul S., Perelson, Alan S., Rong, Libin, Went, Gregory T., Nguyen, Jack T.
Publicado 2011

Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia

por Hauser, Robert A., Pahwa, Rajesh, Wargin, William A., Souza-Prien, Cindy J., McClure, Natalie, Johnson, Reed, Nguyen, Jack T., Patni, Rajiv, Went, Gregory T.
Publicado 2018

Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)

por Pahwa, Rajesh, Tanner, Caroline M., Hauser, Robert A., Sethi, Kapil, Isaacson, Stuart, Truong, Daniel, Struck, Lynn, Ruby, April E., McClure, Natalie L., Went, Gregory T., Stempien, Mary Jean
Publicado 2015

Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro

por Nguyen, Jack T., Hoopes, Justin D., Le, Minh H., Smee, Donald F., Patick, Amy K., Faix, Dennis J., Blair, Patrick J., de Jong, Menno D., Prichard, Mark N., Went, Gregory T.
Publicado 2010